{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:37:05Z","timestamp":1773830225549,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,23]]},"DOI":"10.7759\/cureus.88603","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T16:42:54Z","timestamp":1753288974000},"source":"Crossref","is-referenced-by-count":2,"title":["Trazodone-Induced Ischemic Priapism Successfully Managed With Conservative Therapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Stanislaw","family":"Szymkiewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2009.01625.x","article-title":"Priapism: pathogenesis, epidemiology, and management","volume":"7","author":"Broderick GA","year":"2010","unstructured":"Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010, 7:476-500. 10.1111\/j.1743-6109.2009.01625.x","journal-title":"J Sex Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000087608.07371.ca","article-title":"American Urological Association guideline on the management of priapism","volume":"170","author":"Montague DK","year":"2003","unstructured":"Montague DK, Jarow J, Broderick GA, et al.. American Urological Association guideline on the management of priapism. J Urol. 2003, 170:1318-24. 10.1097\/01.ju.0000087608.07371.ca","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/00365599609182313","article-title":"Preservation of potency after treatment for priapism","volume":"30","author":"Kulmala RV","year":"1996","unstructured":"Kulmala RV, Lehtonen TA, Tammela TL. Preservation of potency after treatment for priapism. Scand J Urol Nephrol. 1996, 30:313-6. 10.3109\/00365599609182313","journal-title":"Scand J Urol Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp-rj.2023.190105","article-title":"Trazodone-induced priapism and increased recurrence risk with antipsychotics","volume":"19","author":"Eisenach C","year":"2023","unstructured":"Eisenach C, Lynch S. Trazodone-induced priapism and increased recurrence risk with antipsychotics. Am J Psychiatry. 2023, 19:2. 10.1176\/appi.ajp-rj.2023.190105","journal-title":"Am J Psychiatry"},{"key":"ref5","unstructured":"Trazodone 150 mg tablets. summary of product characteristics . Accessed: June 2024: https:\/\/www.medicines.org.uk\/emc\/product\/4975\/smpc."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2007.08.006","article-title":"Priapism: current principles and practice","volume":"34","author":"Burnett AL","year":"2007","unstructured":"Burnett AL, Bivalacqua TJ. Priapism: current principles and practice. Urol Clin North Am. 2007, 34:631-42, viii. 10.1016\/j.ucl.2007.08.006","journal-title":"Urol Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2005.037291","article-title":"Medical and surgical management of priapism","volume":"82","author":"Cherian J","year":"2006","unstructured":"Cherian J, Rao AR, Thwaini A, Kapasi F, Shergill IS, Samman R. Medical and surgical management of priapism. Postgrad Med J. 2006, 82:89-94. 10.1136\/pgmj.2005.037291","journal-title":"Postgrad Med J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181c8273d","article-title":"Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity","volume":"30","author":"Andersohn F","year":"2010","unstructured":"Andersohn F, Schmedt N, Weinmann S, Willich SN, Garbe E. Priapism associated with antipsychotics: role of alpha1 adrenoceptor affinity. J Clin Psychopharmacol. 2010, 30:68-71. 10.1097\/JCP.0b013e3181c8273d","journal-title":"J Clin Psychopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2174\/138161205774913345","article-title":"Endothelial nitric oxide synthase gene therapy for erectile dysfunction","volume":"11","author":"Bivalacqua TJ","year":"2005","unstructured":"Bivalacqua TJ, Musicki B, Usta MF, Champion HC, Kadowitz PJ, Burnett AL, Hellstrom WJ. Endothelial nitric oxide synthase gene therapy for erectile dysfunction. Curr Pharm Des. 2005, 11:4059-67. 10.2174\/138161205774913345","journal-title":"Curr Pharm Des"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2174\/1389450115666141111111842","article-title":"Molecular pathophysiology of priapism: emerging targets","volume":"16","author":"Anele UA","year":"2015","unstructured":"Anele UA, Morrison BF, Burnett AL. Molecular pathophysiology of priapism: emerging targets. Curr Drug Targets. 2015, 16:474-83. 10.2174\/1389450115666141111111842","journal-title":"Curr Drug Targets"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/393323-trazodone-induced-ischemic-priapism-successfully-managed-with-conservative-therapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T16:42:55Z","timestamp":1753288975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/393323-trazodone-induced-ischemic-priapism-successfully-managed-with-conservative-therapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.88603","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}